Assessment of Safe-use Conditions for Administration of ZULRESSO in a Home Setting
Latest Information Update: 21 Jul 2023
At a glance
- Drugs Brexanolone (Primary)
- Indications Postnatal depression
- Focus Adverse reactions
- Sponsors Sage Therapeutics
- 02 Aug 2022 Status changed from active, no longer recruiting to completed.
- 15 Jul 2022 Status changed from recruiting to active, no longer recruiting.
- 03 Dec 2021 Status changed from not yet recruiting to recruiting.